Pharma Journalist -

LEATHERHEAD, UK 27th March 2018 – Smithers Rapra will be extending its popular Extractables and Leachables (E&L) conference series into China later this year. Taking place in…
Read More...

Sandoz announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for marketing authorization of…
Read More...

CutisPharma announced that it has been acquired by NovaQuest Capital Management. As a part of the transaction, Goldman Sachs Specialty Lending Group has provided financing to further…
Read More...

Novo Nordisk announced that the US Food and Drug Administration (FDA) approved updates to the prescribing information (PI) for Tresiba (insulin degludec injection) 100 U/mL, 200 U/mL to…
Read More...

Pfizer Inc. announced results from a Phase 4 study evaluating the efficacy and safety of CHANTIX/CHAMPIX (varenicline) for smoking cessation in nicotine dependent adolescents 12-19…
Read More...

Flex Pharma announced positive topline data for FLX-787 from its exploratory Phase 2 trial in MS patients with frequent muscle cramps/spasms and spasticity. “MS patients frequently…
Read More...

SetPoint Medical announced that it has launched a pilot trial for patients with drug refractory rheumatoid arthritis (RA) in the U.S. The multi-center study, “A Randomized Controlled…
Read More...

Acorda Therapeutics announced that it has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for INBRIJA. Acorda is seeking marketing approval…
Read More...

FORMA Therapeutics and Arpeggio Biosciences announced a collaboration to utilize Arpeggio Biosciences’ proprietary technology to supplement FORMA’s analysis of the biological effects of…
Read More...

PharmaCyte Biotech, Inc. announced that it has filed a U.S. patent application with the United States Patent and Trademark Office (USPTO) to protect its therapy to treat cancerous…
Read More...